Cent Eur J Public Health 2005, 13(2):61-65

Epidemiologic Characteristics of Hypertension in the Civilians of Kosovo after the War

Markoglou N.C.1, Hatzitolios A.I.2, Savopoulos C.G.2, Ziakas A.G.2, Koutsopoulos D.1, Metallidis S.2
1 34th Greek Medical Battalion, Greek Force of Kosovo
2 1st Medical Propedeutic Department, Aristotles University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece

34th Greek regimen, which was part of the NATO forces, provided medical services to the civilians of Kosovo. We studied epidemiologic data in the population of Kosovo regarding hypertension in order to determine the prevalence and characteristics of hypertension. 830 patients (281 - 33.86% male, 62± 26 yrs and 549 - 66.14% female, 49± 28 yrs) were examined for different diseases. We identified 254 (30.6%) patients with hypertension (188 female and 66 male). According to the international criteria used for the classification of the severity of hypertension, more than half of the patients (51.2%) had severe hypertension, 31.5% modest and 17.3% mild. Statistically significant relation between the severity of hypertension and age or sex was not found out. Increased BMI as well as the presence of proteinuria and rheumatic diseases were significantly related to the severity of the hypertension while the coexistent heart disease, diabetes mellitus and chronic obstructive pulmonary disease (COPD) wasn't. The use of non-steroid anti-inflammatory agents (NSAIDs) was related to the severity of hypertension with a borderline significance. 31.4% of the patients were on treatment with NSAIDs and/or cortisone because of rheumatic disease or obstructive pulmonary disease. Overfunction of the sympathetic system was present in 62.99%. The mean heart rate was greater in women (84/min) than in men (72/min). 28.35% of the patients had secondary hypertension, including the patients on a drug that can elevate the blood pressure and patients with increased activity of the sympathetic nervous system. So, 8.6% of the patients had usual causes of secondary hypertension and 19.6% hypertension secondary related to the use of NSAIDs or cortisone, or due to the increased activity of the sympathetic nervous system. Antihypertensive treatment was started in 248 patients, i.e. in all of them except the ones already on treatment having their blood pressure well controlled. For antihypertensive treatment β-blockers or central adrenergic inhibitors either as monotherapy or in combination with other agents were used most frequently combined with diuretics and Ca antagonists and ACE inhibitors. In conclusion the diagnosis and treatment of hypertension in the population of Kosovo during the post war period had certain particularities.

Keywords: epidemiology, Kosovo, hypertension, sympathetic nervous system, non-steroid anti-inflammatory drugs, steroids

Received: November 19, 2003; Revised: November 28, 2004; Accepted: November 28, 2004; Published: June 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Markoglou NC, Hatzitolios AI, Savopoulos CG, Ziakas AG, Koutsopoulos D, Metallidis S. Epidemiologic Characteristics of Hypertension in the Civilians of Kosovo after the War. Cent Eur J Public Health. 2005;13(2):61-65. PubMed PMID: 15969452.
Download citation

References

  1. BoitsovSA,KarpenkoMA,KuchminAN,PestovaLV,BelokonGV:Clinical manifestation of hypertension in citizens of siege Leningrad (1941-1944). Retrospective analysis of archive materials. Tel Arkh. 2000; 72: 54-8.
  2. Ramirez MO, Pino CT, Lee AJ: Paraguayan National Blood Pressure Study: prevalence of hypertension in the general population. J Hum Hypertens. 1995; 9: 891-7. Go to PubMed...
  3. Aguero Torres H, Fratiglioni L, Lindberg J, Winbland B: Hypertension in the elderly population: prevalence data from an urban area in Sweden. Aging Milano. 1994; 6: 249-55. Go to original source... Go to PubMed...
  4. Heitzler VN, Bergovec M, Prpic H, et al: Hyperdynamic β-adrenergic syndrome among Croatian soldiers engaged in battle. Wien Med Wchschr. 1993; 143(18): 479-81.
  5. Wyss JM: The role of the sympathetic nervous system in hypertension. Curr Opin Nephrol Hypertens. 1993; 2: 265-73. Go to original source...
  6. Brunjes S: Catecholamine metabolism in essential hypertension. N Engl J Med. 1964; 271: 120-4. Go to original source... Go to PubMed...
  7. Spiegel SB, Salama P: War and mortality in Kosovo, 1998-99: an epidemiological testimony. Lancet. 2000; 355: 2204-9. Go to original source... Go to PubMed...
  8. Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Amery A: The influence of menopause on blood pressure. J Hum Hypertens. 1989; 3(6): 427-33. Go to PubMed...
  9. Mancia G, Sega R, Milesi C, et al: Blood-pressure control in the hypertensive population. Lancet. 1997; 349: 454-457. Go to original source...
  10. Strasser T: Assessing the quality and effects of hypertension control in populations. J Hum Hypertens. 1996; 10 (suppl 3): S1-S8.
  11. Stergiou GS,Thomopoulou GC, Skeva II, MountokalakisTD: Prevalence, awareness, treatment and control of hypertension in Greece: the Didima study. Am J Hypertens. 1999; 12: 959-65. Go to original source...
  12. Pope JE,Anderson JJ, Felson DT:Ametaanalysis of the effects of NSAIDs on B.P. Arch Intern Med. 1993; 153: 477-84. Go to original source...
  13. De Leeuw PW: Nonsteroidal anti-inflammatory drugs and hypertension. The risks in perspective. Drugs. 1996; 51: 179-87. Go to original source... Go to PubMed...
  14. The sixth report of the joint National Committee on Detection. Evaluation and treatment of high blood pressure. (JNC VI). Arch Intern Med. 1997; 157(21): 2413-16.
  15. Matějka J, Bobák M, Vojtíšek P, Franc P: Control of hypertension in the Czech part of the Pardubice-Augsburg Study. Vnitř Lék. 1998; 44(11): 633-6 (in Czech). Go to PubMed...
  16. Blendon RJ, ScheckAC, Donelan K, et al: How white andAfricanAmericans view their health and social problems. JAMA. 1995; 273: 341-46. Go to original source...
  17. Ooi WL, Budner NS, Cohen H, et al: Impact of race on treatment response on cardiovascular disease among hypertensives. Hypertension. 1989; 14: 227-34. Go to original source...
  18. Monane M, Bohn RL, Gurwitz JH: Compliance with antihypertensive therapy among elderly medicaid enrolles: the roles of age gender and race. Am J Publ Health. 1996; 86: 1804-1808. Go to original source...
  19. Brunner HR, Menard J, Waeber B, et al: Treating the individual hypertensive patient. Considerations on dose, sequential monotherapy and drug combinations. J Hypertens. 1990; 8: 3-11. Go to original source...
  20. Kaplan NM: Clinical hypertension. Book chapter: Kaplan NM. Treatment of hypertension. Baltimore:Williams &Wilkins(eds), 7th Ed. 1998: 229-49.
  21. Morgan TO, Anderson A, Bertram D: Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. Am J Hypertens. 2000; 13(11): 1161-70. Go to original source...
  22. Baisac J, Henrich WL: Nephrotoxicity of non-steroidal anti-inflammatory drugs. Miner Electrolyte Metab. 1994; 20: 187-92. Go to PubMed...
  23. WheltonA, Fort JG, Puma JAet al: Cyclooxygenase-2 specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients. Am J Ther. 2001; 8(2): 85-95. Go to original source...
  24. Whelton A: Renal aspects of treatment with conventional nonsteroidal anti-inflammatory drugs versus cyclooxygenase-2-specific inhibitors. Am J Med. 2001; 19(110)Suppl3A: 33S-42S. Go to original source...
  25. Johnson AG: NSAIDs and increased blood pressure. What is the clinical significance? Drug Saf. 1997; 17(5): 277-89. Go to original source... Go to PubMed...
  26. Lindhohn LH, Hansson L, EkbomTet al: Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension-2. Hypertension-2 Study Group. J Hypertens. 2000; 18(11): 1671-5. Go to original source...
  27. Poulter NR, Zographos D, Mattin R, Sever PS, Thom SM: Concomitant risk factors in hypertensives: a survey of risk factors for cardiovascular disease amongst hypertensives in English general practises. Blood Press. 1996; 5(4): 209-15. Go to original source... Go to PubMed...
  28. Ruilope LM, Rodicio JL: Clinical relevance of proteinuria and microalbuminuria. Curr Opin Nephrol Hypertens. 1993; 2: 962-7. Go to original source...
  29. Sagar S, Rosangluaia, Kumari S, Sharma BK: Proteinuria in essential hypertension. Indian J Med Res. 1991; 94: 50-4.
  30. Gosling P, Beevers DG: Urinary albumin excretion and blood pressure in the general population. Clin Sci. 1989; 76: 39-42. Go to original source...
  31. Kordonouri O, Dracou C, Papadellis F, Touroutsika P: Glomerular microproteinuria in children treated with non-steroidal anti-inflammatory drugs for juvenile chronic arthritis. Clin Exp Rheumatol. 1994; 12(5): 567-71. Go to PubMed...
  32. Kuhlmann MK, Kohler H: The RENAAL Study. Effect of losartan on diabetic nephropathy. Internist. 2002; 43(5): 675-7. Go to original source... Go to PubMed...
  33. Mogensen CE: The reno-protective role of AT(1)-receptor blockers. J Hum Hypertens. 2002; 16 (Suppl3): S52-8. Go to original source... Go to PubMed...